Biotron Limited is an Australian biotechnology company developing and commercializing novel therapeutics and diagnostics to address a range of significant health issues.

Biotron's current focus is on development of novel antiviral therapeutics and high-throughput screening technologies for cancer diagnosis. In addition, the Company has a number of early-stage projects targeting other indications such as cardiovascular disease.

RECENT ANNOUNCEMENTS

Year End Accounts and Preliminary Final Report for year ended 30 June 2010

Quarterly Report 30 June 2010

Presentation at International AIDS Conference

 

UPDATE - Southern Cross Equities Analyst report on Biotron Dec 2009

2009 Annual Report

`